 NEW YORK--BUSINESS WIRE--WaterMill Asset Management Corp. together with its affiliates, WaterMill or we today responded to the latest element of the low-road campaign that Ziopharm Oncology, Inc. NASDAQ: ZIOP Ziopharm or the Company is waging in response to our consent solicitation. Robert Postma, principal and founder of WaterMill, commented: This latest chapter of Ziopharms low-road campaign only validates our view that the recent additions of Kevin Buchi and Mary Thistle to 